Janssen Bets US$1.4 B on Mersana’s ADC Platform
By Ashish Tripathi
Pharma Deals Review: Vol 2022 Issue 2 (Table of Contents)
Published: 18 Feb-2022
DOI: 10.3833/pdr.v2022.i2.2670 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In order to strengthen its oncology pipeline, Janssen has agreed to pay US$40 M upfront and committed up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS